Identification of 5-HT receptor subtype mediating 5-HT induced relaxation of porcine pial veins

Biomedical Research (India)

Volumn 11, Issue 2, 2000, Pages 201-208

  Lee, Tony J F ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CAMP; Pial veins; Porcine; Serotonin 5 HT7 receptor; Vasodilation

Indexed keywords

EID: 29644436670     PISSN: 0970938X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Deshmukh VD, Harper AM The effect of serotonin on cerebral and extracerebral blood flow with possible implications in migraine. Acta Neurol Scand 1973; 49: 649-658.
2. Fozard JR, Gray JA 5HTIC receptor activation: a key step in the initiation of migraine? Trends Physiol Sci 1989; 10: 307-309.
3. Saxena PR, Ferrari MD 5HTl-like receptor agonists and the pathophysiology of migraine. Trends Physiol Sci 1989; 10: 200-204.
4. Svendgaard NA, Edvinsson L, Owman C., Shalin C. Increased sensitivity of the basilar artery to norepinephrine and 5-hydroxytryptamine following experimental subarachnoid hemorrhage. Surg Neural 1977; 8: 191-195.
5. Johnson KW, Phebus LA, Cohen ML Serotonin in migraine: theories, animal models and emerging therapies. Prog Drug Res 1998; 51: 219-244.
6. Hamel E. The biology of Serotonin receptors: focus on migraine pathophysiology and treatment. Can J Neurol Sci 1999; 26 suppl 3: S2-6.
7. Nobler MS, Mann JJ, Sackeim HA Serotonin, cerebral blood flow, and cerebral metabolic rate in geriatric major depression and normal aging. Brain Res Brain Res Rev 1999; 30 (3): 250-263.
8. Lee TJF. Recent studies on serotonin-containing fibers in cerebral circulation. In: Neurotransmission and Cerebrovascular Function II, edited by J Seylaz and R Sercombe. Amsterdam: Elsevier, 1989; pp. 133-149.
9. Auer LM, Leber K, Sayama I. Effect of serotonin and its antagonist ketanserin on pial vessels. J Cereb Blood Flow Metab 1985; 5: 517-522.
10. Parsons AA. 5-HT receptors in human and animal cerebrovasculature. Trends Physiol Sci 1991; 12: 310-315.
11. Martin GR. Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol Ther 1994; 62 (3): 283-324.
12. Cohen Z, Bouchelet I, Olivier A., Villemure JG, Ball R, Stanimirovic DB, Hamel E. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J Cereb Blood Flow Metab 1999; 19(8): 908-917.
13. Hoyer D, Martin G. 5-HT receptor classification and nomenclature: Twards a harmonization with the human genome. Neuropharmacology 1997; 36 (4-5): 419-28.
14. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 1999; 38(8): 1083-10152.
15. Terron JA, Falcon-Neri A. Pharmacological evideence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br J Pharmacol 1999; 127 (3): 609-616.
16. Sunagane N, Lee TJF. Serotonin-induced relaxation and constrictions of porcine pial veins in vitro. FASEB J, 1988.
17. Lee TJF, Sunagane N. 5HTI-like receptors mediate pial venous relaxation. In: Neurotransmission and cerebrovascular function 1, edited by J Seylaz and ET Mackenzie. Amsterdam, Elsevier p. 233-236, 1989.
18. Lee TJF, Ueno M, Sunagane N., Sun MH Serotonin relaxes porcine pial veins. Am J Physiol 266 (Heart Circ Physiol 35), 1994; H1000-H1006.
19. Ueno M, Ishine T, Lee TJF. A novel 5-HTI-like receptor subtype mediates cAMP synthesis in the porcine pial vein. Am J Physiol 1995; 268, H1383.
20. Ishine T, Lee TJF. Norepinephrine attenuates serotonin inhibition of pial venous tone. Eur J Pharmacol 1996; 313: 97-102.
21. 7 receptors mediate relaxation of porcine pial veins. Am J Physiol (in press).
22. Auer LM, Mackenzie ET Physiology of cerebral venous system. In: The Cerebral Venous System and Its Disorders, edited by JP Kapp and HH Schmidek. New York, Grune & Stratton 1984 p. 169-227.
23. Hundley WG, Renaldo GJ, Levasseur J.E., Kontos HA Vasomotion in cerebral circulation of awake rabbits. Am J Physiol 254 (Heart Circ Physiol. 23) 1988; H67-H71.
24. Lee TJF, Sarwinski S. Nitric oxidergic neurogenic vasodilation in the porcine basilar artery. Blood Vessels 1991; 28. 407-412.
25. Martin W, Villani GM, Jothianandan D, Furchgott RF Selective blockade of endothelium-dependent glycerol trinitrate-induced relaxation by hemoglobin and methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232: 708-716.
26. Linnik MD, Lee TJF. Effects of hemoglobin on neurogenic responses and cholinergic parameters in porcine cerebral arteries. J Cereb Blood Flow Metab 1989; 9: 219-225.
27. Edvinsson L, Hardebo JE, Owman C. Pharmacological analysis of 5 Hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man. Circ Res 1978; 42: 143-151.
28. Lee TJF, Kinkead, LP, Sarwinski S. Norepineph-rine and acetylcholine transmitter mechanisms in large cerebral arteries of the pig. J Cereb Blood Flow Metab 1982; 2: 439-450.
29. Schoeffter P, Hoyer D. Interaction of arylpiperazines with 5HTIA, 5HTIB, 5HTIC and 5HTID receptors: Do discriminatory 5HTIB receptor ligands exist? Naunyn-Schmiedeberg's Arch Pharmacol 1989; 339: 675-683.
30. Adham N, Kao HT, Schechter L.E., Bard J., Olsen M, Urquhart D, Durkin M., Hartig PR, Weinshank RL Cloning of another human serotonin receptor (5HT1F): A fifth 5HT, receptor subtype coupled to the inhibition of adenylate cyclase. Proc Natl Acad Sci USA 1993; 9D: 408-412.
31. Buzzi MG, Moskowitz MA Evidence for 5HTIB/ID receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia 11-1991; 165-168.
32. Johnson KW, Phebus LA, Cohen ML Serotonin in migraine: theories, animal models and emerging therapies. Prog Drug Res 1998; 51: 219-44.
33. Peroutka SJ, Schmidt AW, Sleight MA Serotonin receptor "families" in the central nervous system: an overview (Part II: Serotonin Receptors). Ann NY Acad Sci 1990; 600: 104-113.
34. Schoeffter P, Hoyer D. Centrally acting hypotensive agents with affinity to 5HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. Br J Pharmacol 1988; 95: 975-985.
35. Schoeffter P, Hoyer D. 5-hydroxytryptamine 5HTIB and 5HTID receptors mediating inhibition of adenyle cyclase activity. Naunyn-Schmiedeberg's Arch Pharmacol 1989; 340: 285-292.
36. Hoyer D. Biochemical mechanism of 5HT receptor-effector coupling in peripheral tissues. In: Peripheral Actions of 5HT, edited by JR Fozard New York: Oxford Univ Press, p. 72-99, 1989.
37. Martin GR, Humphrey PPA. Receptors for 5-hydroxy-tryptamine: Current perspectives on classification and nomenclature. Neuropharmacology 1994; 33: 261-273.
38. Fozard JR. Agonists, antagonists at 5-HT3 receptors. In: The Cardiovascular Pharmacology of 5-Hydroxytryptamine: Prospective Therapeutic Application, edited by PR Saxena, DI Wallis, W Wounters and P Bevan. Dordrecht: Kluwer Academic, 1990, p. 101-115.
39. Munzar P, Laufert MD, Kutkat S.W., Novakova J., Goldberg SR Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther 1999; 291(1): 239-250.
40. Dohlman, HG, Caron, MG, Lefkowitz, RJ. A family of receptors coupled to guanine nucleotide regulatory proteins, Biochemistry 1987; 26 (10), 2657.
41. Asada Y, Lee TJF. α2-adrenoceptors mediate norepinephrine constriction of porcine pial veins, Am J Physiol 1992; 263, H1907-H1910.
42. Shirasaki Y, Kolm P, Nickols G.A., Lee TJF. Endothelial regulation of cyclic GMP and vascular responses in hypertension. J Pharmacol Exp Ther 1988; 245 (1): 53-58.
43. Kitazawa T, Kubo O, Satoh M., Taneike T. Involvement of 5-hydroxytryptamine 7 receptors in inhibition of porcine myometrial contractility by 5-hydroxytryptamine. Br J Pharmacol 1998; 123 (2): 173-182.
44. Adham N, Zgombick JM, Bard J, Branchek TA Funtional characterization of the recombinant human 5-hydroxytryptamine7 (a) receptor isoform coupled to adenylate cyclase stimulation. J Pharmacol Exp Ther 1998; 287 (2): 508-514.
45. Dumuis A, Bouhelal R, Sebben M., Cory R, Bockaert J. A nonclassical 5 hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol. 1988; 34: 880-887.
46. Elswood CJ, Bunce KT, Humphrey PPA. Identification of putative 5-HT4 receptors in guinea-pig ascending colon. Eur J Pharmacol 1991; 196: 149-155.
47. Hamblin MW, Guthrie CR, Kohen R, Heidmann DE Gs protein-coupled serotonin receptors: receptor isoforms and functional differences. Ann N Y Acad Sci 1998; 15; 861: 31-37.
48. Prins NH, Van Haselen JF, Lefebvre RA, Briejer MR, Akkermans LM, Schuurkes JA Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle. Br J Pharmacol 1999 Jul; 127 (6): 1431-1437.
49. Villalon CM, den Boer MO, Heiligers JPC, Saxena PR Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Br J Pharmacol 1991; 102: 107-112.
50. Craig DA, Clarke DE Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine4 receptor. J Pharmacol Exp Ther 1990; 252: 1386-1387.
51. Sebben M, Ansanay H, Bockaert J., Dumuis A. 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture. Neuroreport 1994; 5 (18): 2553-2557.
52. Ruat M, Traiffort E, Arrang J.M., Tardivel-Lacombe J, Diaz J, Leurs R and Schwartz JC. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem. Biophys. Res Commun 1993a; 193 (1): 268-276.
53. Ruat M, Traiffort E, Leurs R., Tardivel-Lacombe J, Diaz J, Arrang J.M., Schwartz JC Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc Natl Acad Sci USA 1993b; 90 (18): 8547-851.
54. Schoeffter P, Ullmer C, Bobirnac I., Gabbiani G, Lubbert H. Functional, endogenously expressed 5-hydroxytryptamine 5ht-7 receptors in human vascular smooth muscle cells. Br J Pharmacol 1996; 117: 993-994.
55. Jasper JR, Kosaka A, To Z.P., Chang DJ, Eglen RM Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7b). Br J Pharmacol 1997; 122 (1): 126-132.
56. Adham N, Zgombick JM, Bard J, Branchek TA Functional characterization of the recombinant human 5-hydroxytryptamine7 (a) receptor isoform coupled to adenylate cyclase stimulation. J Pharmacol Exp Ther. 1998; 287 (2): 508-514.
57. Cushing DJ, Zgombick JM, Nelson D.L., Cohen ML Ly215840, a high affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J Pharmacol Exp Ther 1996; 277: 1560-1566
58. 7 receptor: orphan found. TIPS. 1997; 18: 104-107.
59. Terron JA. The relaxant 5-HT receptor in the dog coronary artery smooth muscle: Pharmacological resemblance to the cloned 5-HT7 receptor subtype. Br J Pharmacol 1996; 118: 1421-1428.
60. Carter D, Huang B, Champney M., Eglen RM Characterization of a postjunctional receptor mediating relaxation of guinea-pig isolated ileum. Eur J Pharmacol 1995; 280: 243-250.
61. Leung E, Walsh LK, Pulido-Rio MT, Eglen RM Characterization of putative 5-ht7 receptors mediating direct relaxation in cynomolgus monkey isolated jugular veins. Br J Pharmacol 1996; 117: 926-930.
62. Dyer SM, de la Lande IS, Frewin DB, Head RJ. 5-Hydroxytryptamine-induced contraction of the marmoset aorta is mediated by a 5-HT1-like receptor. Clin. Exp. Pharmacol. Physiol. 1998; 25 (3-4): 246-251.
63. Martin GR, Wilson RJ Operational characteristics of a 5-HT receptor mediating direct vascular relaxation: Identity with the 5-HT7 receptor? Br J Pharmacol 1995; 114: 383.
64. Morecroft I, MacLean MR 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries. Br J Pharmacol 1998; 125 (1): 69-78.
65. Ullmer C, Schmuck K, Kalkman H.O., Lubbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS letters 1995; 370: 215-221.
66. Terron JA. Role of 5-ht7 receptors in the long-lasting hypotensive response induced by 5 hydroxytryptamine in the rat. Br J Pharmacol 1997; 121: 563-571.
67. Villalon CM, Centurion D, Lujan-Estrada M, Terron J.A., Sanchez-Lopez A. Mediation of 5-HT induced external carotid vasodilation in GR-127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptors. Br J Pharmacol 1997; 120: 1319-1327.
68. De Vries P., Villalon CM, Heiligers J.P., Saxena PR Nature of 5-HTl-like receptors mediating depressor responses in vagosympathectomized rats: close resemblance to the cloned 5ht7 receptors. Naunyn Schmiedebergs Arch. Pharmacol 1997; 350: 90-99.
69. Harder DR. Pressure-dependent depolarization in cat middle cerebral artery. Circ Res 1984; 55: 197-202.
70. Deckert V, Pruneau D, Elghozi JL Mediation by 5-HT1D receptors of 5-hydroxytryptamine induced contractions of rabbit middle and posterior cerebral arteries. Br J Pharmacol 1994; 112 (3): 939-945.
71. Miranda FJ, Torregrosa G, Salom J.B., Alabadi JA, Jover T, Barbera MD, Alborch E. Characterization of 5-hydroxytryptamine receptors in goat cerebral arteries. Gen Pharmacol 1995; 26 (6): 1267-1272.
72. Deliganis AV, Peroutka SJ 5-Hydroxtryptamine 1D receptor agonism predicts antimigraine efficacy. Headache 1991; 31(4): 228-231.
73. Petty MA, Elands J, Johnson M.P., Linnik MD, Hamel E, Moskowitz MA, Lee W.S., McCarty DR, Hibert M, Baron BM The selectivity of MDL 74, 721 in models of neurogenic versus vascular components of migraine. Eur J Pharmacol 1997; 336 (2-3): 127-136.
74. Zgombick JM, Borden LA, Cochran T.L., Kucharewicz SA, Weinshank RL, Branchek TA Dual coupling of cloned human 5-hydroxytryptamine ID alpha and 5-hydroxytryptamine 1D beta receptors stably expressed in murine fibroblasts: inhibition of adenylte cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein (s). Mol Pharmacol 1993; 44 (3): 575-82.
75. Sumner MJ, Humphrey PP Sumatriptan (GR43175) inhibits cyclic-AMP accumulation in dog isolated saphenous vein. Br J Pharmacol 1990; 99 (2): 219-220.